Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis - Top-Institutions - MDSpire

Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis

  • By

  • Ting Tang

  • Qiwen Feng

  • Youran Cai

  • Yuying Dong

  • Jian Chen

  • Rijia Zhang

  • Qing Zhou

  • May 22, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    First Affiliated Hospital of Jinan University
    First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong

    Key Differentiators

    • Neurology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology

Original Source(s)

Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis

  • by Ting Tang, Qiwen Feng, Youran Cai, Yuying Dong, Jian Chen, Rijia Zhang, Qing Zhou

  • May 22, 2026

Related Content

New Target for Uveitis Therapy

Could targeting cGAS-STING represent a new treatment avenue for uveitis?

  • May 21, 2026

  • 3 min
From Babylon to Berlin

Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine

Accidental intravitreal injection of a veterinary inactivated FMD vaccine resulting in noninfectious intraocular inflammation: a case report